Editorial: Best surgical treatment of breast cancer managed primarily with neoadjuvant medical therapy
Saved in:
| Main Author: | Ugo Marone |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Surgery |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fsurg.2025.1638260/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the survival outcomes in clinical node stage 2 and 3 breast cancer patients with negative sentinel lymph node biopsy after neoadjuvant chemotherapy: sentinel lymph node biopsy alone vs. axillary lymph node dissection
by: Eunju Shin, et al.
Published: (2025-05-01) -
Clinical study of 99mTc-Rituximab combined with dyes double tracing for axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer
by: Minxue Zhuang, et al.
Published: (2025-08-01) -
Four Node Sampling: Is It an Effective Alternative to Sentinel Lymph Node Biopsy in Low-resource Settings for Breast Cancer Management
by: Sreehari Pothina, et al.
Published: (2025-05-01) -
The role of infraclavicular and supraclavicular lymph nodes in breast cancer patients receiving neoadjuvant chemotherapy: implications for regional lymph node classification
by: Yanyu Chen, et al.
Published: (2025-08-01) -
Analysis of the Clinical Molecular Characteristics and Neoadjuvant Chemotherapy Response in Patients with Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer and Axillary Lymph Node Metastasis
by: Jin-Ping Ma, et al.
Published: (2022-06-01)